rTMS in Improving Neuropathy in Patients With Stage I-IV Cancer Who Have Received Oxaliplatin Chemotherapy
Clinical trial NCT03219502 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03219502
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-10
- Primary completion
- 2027-04-30
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.